GB2502348A — Inhaler with blister piercing mechanism
Assigned to Vectura Delivery Devices Ltd · Expires 2013-11-27 · 12y expired
What this patent protects
An inhaler comprising a housing to receive a strip having a plurality of blisters, a blister drive member 57 which rotates about a first axis, a mouthpiece 202 mounted to the housing and a cap 201 that covers the mouthpiece 202 in a closed position and rotates about a second axis…
USPTO Abstract
An inhaler comprising a housing to receive a strip having a plurality of blisters, a blister drive member 57 which rotates about a first axis, a mouthpiece 202 mounted to the housing and a cap 201 that covers the mouthpiece 202 in a closed position and rotates about a second axis C. The first and second axes are parallel and spaced apart. Rotation of the cap 201 to uncover the mouthpiece 202 causes the blister drive member 57 to rotate an unopened blister into alignment with the mouthpiece 202 and then actuates a blister piercing member 210 to puncture the blister, releasing the contents. A drive gear 16 may couple the cap 201 and blister drive member 57 during at least part of the cap motion.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.